August 17, 2013 --Kenya and Rwanda have partnered with the United Kingdom in a HIV/Aids vaccine trial in a fresh effort to find a cure for the disease.
Phase 1 trials, which are scheduled to kick off before the end of this month, will be conducted by scientists at the Kenya Aids Vaccine Initiative (KAVI) in Nairobi and St Stephen’s Centre in London.
The studies are funded by the International Aids Vaccine Initiative (IAVI), a non-profit organisation based in New York.
Researchers from both institutions will recruit up to 64 healthy adult volunteers aged between 18 and 50 for the trial, which is expected to take up to two years.
Read the rest of the article here.